The DOI matches its Crossref record.
Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652
Open accessAbstract
Pharmacological blockade of the Human ether‐a‐go‐go related gene (HERG) potassium channel is commonly linked with acquired long QT syndrome and associated proarrhythmia. The objectives of this study were (i) to identify and characterise any inhibitory action on HERG of the selective‐serotonin re‐uptake inhibitor fluvoxamine, (ii) to then determine whether fluvoxamine shared the consensus molecular determinants of HERG blockade of those drugs so far tested. Heterologous HERG potassium current (IHERG) was measured at 37°C, using the whole‐cell patch‐clamp technique, from a mammalian cell line (Human embryonic kidney 293) expressing HERG channels. IHERG tails, following repolarisation from +20 to −40 mV, were blocked by fluvoxamine with an IC 50 of 3.8 μM. Blockade of wild‐type HERG was of extremely rapid onset (within 10 ms) and showed voltage dependence, with fluvoxamine also inducing a leftward shift in voltage‐dependent activation of IHERG. Characteristics of block were consistent with a component of closed channel (or extremely rapidly developing open channel) blockade and dependence on open and inactivated channel states. The attenuated‐inactivation mutation S631A partially reduced the blocking effect of fluvoxamine. The S6 mutations, Y652A and F656A, and the pore helix mutant S631A only partially attenuated blockade by fluvoxamine at concentrations causing profound blockade of wild‐type HERG. All HERG‐blocking pharmaceuticals studied to date have been shown to block F656 mutant channels with over 100‐fold reduced potency compared to their blockade of the wild‐type channel. Fluvoxamine is therefore quite distinct in this regard from previously studied agents. British Journal of Pharmacology (2003) 139, 887–898. doi:10.1038/sj.bjp.0705335
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pharmacology of cardiac potassium channels
Tamargo, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.026 · Cited by 466
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Hancox, J. C., McPate, M. J., El Harchi, A., & Zhang, Y. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.009 · Cited by 299
Self-citationRecanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Rodriguez-Menchaca, A., Ferrer-Villada, T., Lara, J., Fernandez, D., Navarro-Polanco, R. A., & Sanchez-Chapula, J. A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000191564.52242.00 · Cited by 39
Metadata
- Authors
- Milnes, J. T., Crociani, O., Arcangeli, A., Hancox, J. C., & Witchel, H. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-07
- Volume
- 139
- Issue
- 5
- Pages
- 887-898
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1987388257
- Cited by
- 175
- References
- 0
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. https://app.cochat.ai/papers/10.1038/sj.bjp.0705335
- The paper
- Milnes, J. T., Crociani, O., Arcangeli, A., Hancox, J. C., & Witchel, H. J. (2003). Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705335
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.